These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 39116523

  • 1. Directing novel ChoKα1 inhibitors using MamC-mediated biomimetic magnetic nanoparticles: a way to improve specificity and efficiency.
    Sola-Leyva A, Jabalera Y, Jimenez-Carretero M, Lázaro M, Pozo-Gualda T, García-Vargas PJ, Luque-Navarro PM, Fasiolo A, López-Cara LC, Iglesias GR, Paz Carrasco-Jiménez M, Jiménez-López C.
    Bioorg Chem; 2024 Oct; 151():107693. PubMed ID: 39116523
    [Abstract] [Full Text] [Related]

  • 2. Biomimetic Magnetic Nanocarriers Drive Choline Kinase Alpha Inhibitor inside Cancer Cells for Combined Chemo-Hyperthermia Therapy.
    Jabalera Y, Sola-Leyva A, Peigneux A, Vurro F, Iglesias GR, Vilchez-Garcia J, Pérez-Prieto I, Aguilar-Troyano FJ, López-Cara LC, Carrasco-Jiménez MP, Jimenez-Lopez C.
    Pharmaceutics; 2019 Aug 12; 11(8):. PubMed ID: 31408964
    [Abstract] [Full Text] [Related]

  • 3. Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1).
    Schiaffino-Ortega S, Baglioni E, Mariotto E, Bortolozzi R, Serrán-Aguilera L, Ríos-Marco P, Carrasco-Jimenez MP, Gallo MA, Hurtado-Guerrero R, Marco C, Basso G, Viola G, Entrena A, López-Cara LC.
    Sci Rep; 2016 Mar 31; 6():23793. PubMed ID: 27029499
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The importance of cell uptake in photothermal treatments mediated by biomimetic magnetic nanoparticles.
    Lázaro M, Lupiáñez P, Sola-Leyva A, Pozo-Gualda T, Oltolina F, Jimenez-Carretero M, Jimenez-Lopez C, Carrasco-Jiménez MP, Iglesias GR.
    Colloids Surf B Biointerfaces; 2024 Feb 31; 234():113722. PubMed ID: 38160473
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line.
    Gómez-Pérez V, McSorley T, See Too WC, Konrad M, Campos JM.
    ChemMedChem; 2012 Apr 31; 7(4):663-9. PubMed ID: 22278967
    [Abstract] [Full Text] [Related]

  • 9. pH-Dependent Adsorption Release of Doxorubicin on MamC-Biomimetic Magnetite Nanoparticles.
    García Rubia G, Peigneux A, Jabalera Y, Puerma J, Oltolina F, Elert K, Colangelo D, Gómez Morales J, Prat M, Jimenez-Lopez C.
    Langmuir; 2018 Nov 13; 34(45):13713-13724. PubMed ID: 30394747
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. New non-symmetrical choline kinase inhibitors.
    Schiaffino-Ortega S, López-Cara LC, Ríos-Marco P, Carrasco-Jimenez MP, Gallo MA, Espinosa A, Marco C, Entrena A.
    Bioorg Med Chem; 2013 Nov 15; 21(22):7146-54. PubMed ID: 24080101
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. mAb-Functionalized Biomimetic MamC-Mediated-Magnetoliposomes as Drug Delivery Systems for Cancer Therapy.
    Oltolina F, Santaella Escolano MDC, Jabalera Y, Prat M, Jimenez Lopez C.
    Int J Mol Sci; 2023 Sep 11; 24(18):. PubMed ID: 37762260
    [Abstract] [Full Text] [Related]

  • 16. Enhanced Cytotoxic Effect of TAT-PLGA-Embedded DOXO Carried by Biomimetic Magnetic Nanoparticles upon Combination with Magnetic Hyperthermia and Photothermia.
    Jabalera Y, Sola-Leyva A, Gaglio SC, Carrasco-Jiménez MP, Iglesias GR, Perduca M, Jimenez-Lopez C.
    Pharmaceutics; 2021 Jul 28; 13(8):. PubMed ID: 34452129
    [Abstract] [Full Text] [Related]

  • 17. (Q)SAR studies to design new human choline kinase inhibitors as antiproliferative drugs.
    Campos JM, Sánchez-Martín RM, Conejo-García A, Entrena A, Gallo MA, Espinosa A.
    Curr Med Chem; 2006 Jul 28; 13(11):1231-48. PubMed ID: 16712467
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors.
    Rubio-Ruíz B, Conejo-García A, Ríos-Marco P, Carrasco-Jiménez MP, Segovia J, Marco C, Gallo MA, Espinosa A, Entrena A.
    Eur J Med Chem; 2012 Apr 28; 50():154-62. PubMed ID: 22348828
    [Abstract] [Full Text] [Related]

  • 20. Acid ceramidase as a chemotherapeutic target to overcome resistance to the antitumoral effect of choline kinase α inhibition.
    Ramírez de Molina A, de la Cueva A, Machado-Pinilla R, Rodriguez-Fanjul V, Gomez del Pulgar T, Cebrian A, Perona R, Lacal JC.
    Curr Cancer Drug Targets; 2012 Jul 28; 12(6):617-24. PubMed ID: 22515519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.